<DOC>
	<DOC>NCT02569749</DOC>
	<brief_summary>To assess the incidence of Sleep Apnea-Hypopnea Syndrome (SAHS), both obstructive and central, in patients with: 1) pacemaker indication; 2) implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRTD), 3) heart failure and preserved left ventricular ejection fraction (LVEF) and 4) heart failure and reduced LVEF.</brief_summary>
	<brief_title>Sleep Apnea Screening</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Age 18 years or older No previous diagnosis of sleep apnea Fulfilling at least one of the following: 1. Pacemaker indication 2. ICD or CRTD therapy indication 3. Heart failure and preserved LVEF (4050%) 4. Heart failure and reduced LVEF (&lt;40%) Signed informed consent Age younger than 18 years Renal hemodialysis Cardiac transplant indication Women who are pregnant Advanced cancer Enrollment in another investigational study Able and willing to comply with all testing and requirements Patient not suitable for inclusion due to psychiatric conditions or short life expectancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>